Bush Administration News
Most Popular Bush Administration Story
Budget has mandate for biogeneric approvals
Buried in the modest 5.7 percent budget hike for the FDA is a provision that the government will seek authority to begin approving generic versions of biologics. Despite heavy support for the... Read more...
Latest Headlines
- April 10, 2008
- February 27, 2008
- February 5, 2008
- July 24, 2007
- January 4, 2007
- December 21, 2006
- November 29, 2006
- November 7, 2006
- November 5, 2006
- August 20, 2006
- July 23, 2006
- July 19, 2006
- May 9, 2006
- April 3, 2006
- March 29, 2006
- March 15, 2006
- March 9, 2006
- October 31, 2005
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
